• Indirect cost changes under OMB Uniform Guidance

    For recipients of federal awards that currently have a negotiated indirect cost rate, there is now a requirement that all federal awarding agencies accept this negotiated rate unless otherwise required by federal statute or regulation or when approved based on documented justification.
  • Banking brief: A bank consolidation wave is forming

    As has been anticipated since the end of the Great Recession, a wave of bank consolidation is very much in formation and could swell to significant levels later in 2015. On its own merit, the increase in average pricing on Q1 2015 deals to a level of just over 150% of book value strongly indicates a more robust mergers and acquisition market for banks.
  • Strengthening collaboration between internal audit and risk management

    To meet OCC requirements and strategically connect the dots on assurance, compliance, and risk management, internal audit functions will need to be part of the risk management ecosystem and provide validation of the execution of risk management responsibilities by frontline units and management. This article outlines what internal audits bring to the table as well as opportunities for driving value through collaboration between risk management and internal audit, using the case example of concern about loan loss reserves.
  • The pulse of healthcare: Baker Tilly healthcare update April 7, 2015

    The Department of Health and Human Services (HHS) recently released a report that showed a decrease in hospital uncompensated care costs due to Medicaid expansion as a result of the Affordable Care Act (ACA). In April the Centers for Medicare and Medicaid Services (CMS) announced that it would delay implementation of the “two-midnight” rule until April 30. Read more to stay on pulse.
  • A Value-Based Analysis of Hemodynamic Support Strategies for High-Risk Heart Failure Patients Undergoing a Percutaneous Coronary Intervention

    The cost of heart disease is a growing burden on the healthcare system. As new technologies for treating heart disease become available, decision-makers need to understand their options. It is important to understand the short-term and long-term options, as well as the costs associated with these new technologies. This article uses big data analytics to take a look at the cost-effectiveness of a new heart pump technology to assist decision-makers in forming a value-based judgment relative to its application.